Table 6.
Characteristics
|
HR (95%CI)
|
Wald
|
P
value
|
Age in yr | 1.289 (0.971-1.710) | 3.076 | 0.079 |
> 60 | |||
≤ 60 | |||
Degree of differentiation | 31.261 | < 0.001 | |
Poorly/well | 5.209 (2.837-9.562) | 28.353 | < 0.001 |
Moderately/well | 1.912 (1.184-3.085) | 7.037 | 0.008 |
Capsular invasion | 0.697 (0.475-1.022) | 3.409 | 0.065 |
Absent | |||
Present | |||
Maximum tumor diameter in cm | 1.296 (0.959-1.751) | 2.843 | 0.092 |
> 4 | |||
≤ 4 | |||
Number of metastatic lymph nodes | 0.678 (0.509-0.904) | 7,027 | 0.008 |
Absent | |||
Present | |||
Adjuvant therapy | 1.604 (1.214-2.118) | 11.058 | 0.001 |
Absent | |||
Present | |||
Preoperative CA19-9 level in U/mL | 1.740 (1.288-2.352) | 13.003 | < 0.001 |
> 336.4 | |||
≤ 336.4 | |||
Preoperative FAR | 2.258 (1.720-2.963) | 34.468 | < 0.001 |
> 0.08 | |||
≤ 0.08 |
CI: Confidence interval; FAR: Fibrinogen-to-albumin ratio; HR: Hazard ratio.